EP2328550A4 - Mukoadhärente zusammensetzungen und ihre verwendung - Google Patents

Mukoadhärente zusammensetzungen und ihre verwendung

Info

Publication number
EP2328550A4
EP2328550A4 EP09806251.6A EP09806251A EP2328550A4 EP 2328550 A4 EP2328550 A4 EP 2328550A4 EP 09806251 A EP09806251 A EP 09806251A EP 2328550 A4 EP2328550 A4 EP 2328550A4
Authority
EP
European Patent Office
Prior art keywords
compositions
mucoadherents
vaginal
bioadhesivity
mucoadherent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09806251.6A
Other languages
English (en)
French (fr)
Other versions
EP2328550A1 (de
Inventor
Haline Fernanda Santana Castanho
Lupercio Calefe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biolab Sanus Farmaceutica Ltda
Eurofarma Laboratorios Ltda
Original Assignee
Biolab Sanus Farmaceutica Ltda
Eurofarma Laboratorios Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolab Sanus Farmaceutica Ltda, Eurofarma Laboratorios Ltda filed Critical Biolab Sanus Farmaceutica Ltda
Publication of EP2328550A1 publication Critical patent/EP2328550A1/de
Publication of EP2328550A4 publication Critical patent/EP2328550A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EP09806251.6A 2008-08-14 2009-08-14 Mukoadhärente zusammensetzungen und ihre verwendung Withdrawn EP2328550A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0803568A BRPI0803568B8 (pt) 2008-08-14 2008-08-14 composição mucoaderente
PCT/BR2009/000255 WO2010017614A1 (en) 2008-08-14 2009-08-14 Mucoadherents compositions and their use

Publications (2)

Publication Number Publication Date
EP2328550A1 EP2328550A1 (de) 2011-06-08
EP2328550A4 true EP2328550A4 (de) 2013-11-20

Family

ID=41668595

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09806251.6A Withdrawn EP2328550A4 (de) 2008-08-14 2009-08-14 Mukoadhärente zusammensetzungen und ihre verwendung

Country Status (14)

Country Link
US (1) US20110218166A1 (de)
EP (1) EP2328550A4 (de)
JP (1) JP2011530541A (de)
KR (1) KR20110050511A (de)
CN (1) CN102170860A (de)
AR (1) AR073034A1 (de)
AU (1) AU2009281647A1 (de)
BR (1) BRPI0803568B8 (de)
CA (1) CA2733724A1 (de)
CO (1) CO6341543A2 (de)
IL (1) IL211204A0 (de)
MX (1) MX2011001739A (de)
RU (1) RU2011109393A (de)
WO (1) WO2010017614A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
US20110028566A1 (en) * 2009-05-15 2011-02-03 Eastman Chemical Company Compositions and products containing cycloaliphatic diol antimicrobial agents and methods of using the compositions and products
SI23309A (sl) * 2010-03-22 2011-09-30 Kemijski inštitut Kombinacija protiglivne substance in motilca znotrajcelične protonske homeostaze za uničevanje ali inhibicijo rasti in replikacije gliv
CN102293735B (zh) * 2011-08-19 2013-05-01 辽宁万嘉医药科技有限公司 一种抗真菌咪唑类药物缓释凝胶和制备方法
EA201590008A1 (ru) * 2012-06-13 2015-05-29 Ивофем, Инк. Композиции и способы повышения эффективности бактерицидных средств контрацепции
EP3025709B1 (de) * 2014-11-27 2020-09-30 Capsugel Belgium NV Darreichungsformartikel für externe Schleimhautanwendungen
KR101882820B1 (ko) * 2015-12-30 2018-07-30 주식회사 삼양바이오팜 점막부착성 약학 조성물 및 그의 제조방법
CN106265486A (zh) * 2016-08-18 2017-01-04 滨州医学院附属医院 一种硝酸咪康唑缓释凝胶及其制备方法
US20230346724A1 (en) * 2018-10-09 2023-11-02 Crapaud Bio Inc. Methods of Making and Using pH Modulating Compositions in the Reproductive System
CN110575431B (zh) * 2019-08-28 2021-08-03 南京天朗制药有限公司 一种阴道酸碱缓冲凝胶及制备方法
CN112933109A (zh) * 2021-02-03 2021-06-11 湖南奥朗特医疗器械有限公司 一种阴道pH调节剂及其制备方法和应用
CN113940915B (zh) * 2021-12-07 2024-04-26 南京麦澜德医疗科技股份有限公司 一种阴道内用凝胶及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999013862A2 (en) * 1997-09-12 1999-03-25 Columbia Laboratories (Bermuda) Limited A pharmaceutical composition for treating dysmenorrhea and premature labor
WO2002051382A2 (en) * 2000-12-27 2002-07-04 University Of Kentucky Research Foundation Ph-sensitive mucoadhesive film-forming gels and wax-film composites
WO2003037381A1 (en) * 2001-10-29 2003-05-08 Columbia Laboratories (Bermuda) Limited Vaginally administerd anti-dysrhythmic agents for treating pelvic pain and infertility
EP1652535A1 (de) * 2003-07-16 2006-05-03 Italfarmaco, S.A. Halbfeste mukoadhäsive formulierungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2661274A1 (en) * 2006-08-29 2008-03-06 University Of Kentucky Research Foundation Compositions and methods for oral cancer chemoprevention using berry preparations and extracts

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999013862A2 (en) * 1997-09-12 1999-03-25 Columbia Laboratories (Bermuda) Limited A pharmaceutical composition for treating dysmenorrhea and premature labor
WO2002051382A2 (en) * 2000-12-27 2002-07-04 University Of Kentucky Research Foundation Ph-sensitive mucoadhesive film-forming gels and wax-film composites
WO2003037381A1 (en) * 2001-10-29 2003-05-08 Columbia Laboratories (Bermuda) Limited Vaginally administerd anti-dysrhythmic agents for treating pelvic pain and infertility
EP1652535A1 (de) * 2003-07-16 2006-05-03 Italfarmaco, S.A. Halbfeste mukoadhäsive formulierungen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2010017614A1 *

Also Published As

Publication number Publication date
CA2733724A1 (en) 2010-02-18
CN102170860A (zh) 2011-08-31
US20110218166A1 (en) 2011-09-08
CO6341543A2 (es) 2011-11-21
JP2011530541A (ja) 2011-12-22
AR073034A1 (es) 2010-10-06
BRPI0803568A2 (pt) 2010-06-15
AU2009281647A1 (en) 2010-02-18
WO2010017614A1 (en) 2010-02-18
RU2011109393A (ru) 2012-09-20
KR20110050511A (ko) 2011-05-13
MX2011001739A (es) 2011-07-05
EP2328550A1 (de) 2011-06-08
BRPI0803568B8 (pt) 2021-05-25
IL211204A0 (en) 2011-04-28
BRPI0803568B1 (pt) 2020-10-13

Similar Documents

Publication Publication Date Title
EP2328550A4 (de) Mukoadhärente zusammensetzungen und ihre verwendung
MX350761B (es) Inhibidores de isoindolinona de fosfatidilinositol 3-cinasa.
UA108743C2 (uk) Похідні хіназолін-4(3н)-ону для застосування як інгібіторів рі3-кінази
MX346336B (es) Derivados de quinazolin-4 (3h)-ona utilizados como inhibidores de pi3 cinasa.
MX2011013032A (es) Inhibidores de fosfatidilinositol 3-cinasa.
MY166789A (en) Arginine salts and their uses for the treatment of illnesses in the oral cavity
IN2012DN01233A (de)
GEP20156366B (en) Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
MY150855A (en) Oral compositions containing extracts of zizyphus joazeiro and related methods
IN2012DN02081A (de)
EP2381957A4 (de) Therapeutische modulation der vaginalepithelrandbefeuchtung
EA019744B9 (ru) Изотиазолилоксифениламидины и их применение для борьбы с фитопатогенными грибами и семенной материал, обработанный изотиазолилоксифениламидинами
MX2011011950A (es) Composiciones de dexmedetomidina sublinguales y metodos de uso de las mismas.
MX2011006006A (es) Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos.
MX365650B (es) Composiciones de amantadina y metodos para su uso.
MX342947B (es) Tratamiento de diabetes tipo 2.
MX2010000266A (es) Un método para disminuir los síntomas del consumo de alcohol.
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
MY182983A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
MX2010009624A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1.
MY150931A (en) Substituted oxazolidinones and their use
MX2013002118A (es) 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX2012000954A (es) Composicion far,aceutica topica que incuye la rel-n-[6-[(2r,6s)-2,6-dimetil-4-morfolinil]-3-piridinil]-2-metil- 4'-(trifluoro-metoxi)-[1,1'-bifenil]-3-carboxamida.
MX2011008645A (es) Inhibidores de tetrahidrotiazolopiridina de fosfatidilinositol 3 cinasa.
MX2012000178A (es) 2-carboxamida-cicloamino-ureas utiles como inhibidores de pi3k.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110314

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: EUROFARMA LABORATORIOS S.A.

Owner name: BIOLAB SANUS FARMACEUTICA LTDA.

A4 Supplementary search report drawn up and despatched

Effective date: 20131017

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/00 20060101AFI20131011BHEP

Ipc: A61P 15/02 20060101ALI20131011BHEP

Ipc: A61K 47/32 20060101ALI20131011BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140301